Peripheral Artery Disease (PAD)
Mar 31, 2023
Peripheral Artery Disease Treatment: Role of Cell Therapies in Restoring Blood Circulation & Limb Function
Peripheral artery disease (PAD) is one of the leading causes of cardiovascular morbidity, affecting 12-14% of the world’s population. Peripheral artery disease affects six times more people worldwide than HIV. 1 in 3 diabetics over age 50 suffer from peripheral artery disease. In addition, 1 in every 20 Americans o...
Read More...
Sep 29, 2022
Asahi Intecc Partners with Penumbra; Prosoma and EVERSANA Announce Commercialisation Partnership; Zynex Starts Enrollment in the Blood Loss Detection Clinical Trial; Reva Initiates Enrollment in the MOTIV IDE Clinical Trial; FDA Clearance to QT Imaging to Calculate Fibroglandular Volume of the Breast; FDA 510k Clearance to iMediSync’s EEG scanner ‘iSyncWave’
Asahi Intecc partners with Penumbra to roll out Indigo System in Japan On September 22, 2022, Asahi Intecc, a Surgical and medical instrument manufacturing company, partnered with Penumbra, a medical device company headquartered in Alameda, California, to roll out Indigo System in Japan. After getting regulat...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
